First-quarter financial results of ReBuilder Medical Technologies announced

NewsGuard 100/100 Score
Editorial Checklist Reviewed
Aug 26 2009

ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM) a provider of electronic treatments for the pain resulting from Peripheral Neuropathy and Peripheral Artery Disease today announced that it has turned the corner and is now reporting profits for the first Quarter of 2009.

"Our efforts to become profitable have been successful," said David Phillips, Ph.D. CEO., "and now we look forward to maintaining our momentum."

Additionally, Dr. Phillips reports: "We have abandoned our efforts to change the name of the company and it will remain as it is with no change in cusip number."

Finally, Dr. Phillips told reporters today: "We will have much more positive financial news to report in the next few days."

Source:

http://www.rebuildermedical.com 

Posted in:

Tags: , , ,

Comments (0)

Suggested Reading

Research finds link between unhealthy eating and chronic pain severity, calls for comprehensive dietary support
Childhood trauma linked to higher rates of somatic symptoms, study finds
Study highlights anti-inflammatory properties of herbal medicine, Erigeron breviscapus to treat osteoarthritis
Plant-based diets trigger remission in Sjögren's syndrome and lupus cases
Examining how pain could play a direct protective role in the gut
Caffeine vs. creatine: The impact on cognitive and physical performances
Study reveals nerve changes linked to pain and urinary frequency in recurrent UTI sufferers
Could vitamin D levels be associated with lower back pain?

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Does diabetes increase the risk of long COVID?